InsidersTradesSigma
Total declarations
Company
▲ Purchases (9 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
9
Disclosed sells
4
T+90 hit rate
100%
T+90 mean return
+3.4%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Polymeropoulos Mihael Hristos, Chief Executive Officer. Director active across 1 company, notably Vanda Pharmaceuticals Inc.. Cumulatively, 25 disclosures have been logged. Split: 9 buys · 4 sells. Total volume traded: €1.7m. History available since 30 November 2021. The latest transaction was filed on 2 March 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Polymeropoulos Mihael Hristos
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
156,235 shares@ US$8.173440.4% of flowCommon StockSEC:0001355537-26-000002:0
525,000 shares0Common StockSEC:0001193125-26-059770:0
10,000 shares@ US$4.152.2% of flowCommon StockSEC:0000950170-25-105819:0
Canonical exit: 5 Nov 2025 (T+90)
9,519 shares@ US$4.401.9% of flowCommon StockSEC:0000950170-25-076012:0
Canonical exit: 19 Aug 2025 (T+90)
20,000 shares@ US$4.22364.0% of flowCommon StockSEC:0000950170-25-074565:0
Canonical exit: 14 Aug 2025 (T+90)
5,000 shares@ US$5.021.2% of flowCommon StockSEC:0000950170-25-034966:0
Canonical exit: 4 Jun 2025 (T+90)
5,000 shares@ US$5.011.2% of flowCommon StockSEC:0000950170-25-033845:0
Canonical exit: 3 Jun 2025 (T+90)
95,999 shares@ US$4.7623.1% of flowCommon StockSEC:0000950170-25-032276:0
10,000 shares@ US$4.762.4% of flowCommon StockSEC:0000950170-25-030176:0
Canonical exit: 29 May 2025 (T+90)
10,000 shares@ US$4.762.4% of flowCommon StockSEC:0000950170-25-029059:0
Canonical exit: 28 May 2025 (T+90)
5,000 shares@ US$4.751.2% of flowCommon StockSEC:0000950170-25-027860:0
Canonical exit: 27 May 2025 (T+90)
10,000 shares@ US$4.4642.2% of flowCommon StockSEC:0000950170-25-027056:0
Canonical exit: 26 May 2025 (T+90)
450,000 shares0Common StockSEC:0000950170-25-024489:0
30,884 shares@ US$4.24386.3% of flowCommon StockSEC:0000950170-24-027256:0
450,000 shares0Common StockSEC:0000950170-24-018030:0
22,426 shares@ US$6.23026.9% of flowCommon StockSEC:0001209191-23-016462:0
115,000 shares0Common StockSEC:0001209191-23-011341:0
74,635 shares@ US$3.1211.6% of flowCommon StockSEC:0001209191-22-060227:0
115,000 shares0Common StockSEC:0001209191-22-015157:0
78,324 shares@ US$4.8812.6% of flowCommon StockSEC:0001209191-21-067592:0
12,500 sharesCommon StockSEC:0001209191-16-090127:0
6,250 sharesCommon StockSEC:0001209191-16-090127:1
12,500 sharesCommon StockSEC:0001209191-16-090127:2
12,500 sharesCommon StockSEC:0001209191-16-090127:3
21,353 sharesCommon StockSEC:0001209191-16-090127:4
25 of 25 declarations
About Polymeropoulos Mihael Hristos
Polymeropoulos Mihael Hristos is President and CEO at Vanda Pharmaceuticals Inc. The declarant has 25 filings in total, and across the 25 sampled filings, the buy and sell amounts are EUR 351210 and EUR 1337748, respectively, over the period from 2016-01-06 to 2026-03-04; the most frequent transaction nature is Acquisition.
